Linkage Biosciences Partners With Italian Distributor

April 27, 2015 |

1 min read

SAN FRANCISCO, CA--(Marketwired - April 27, 2015) -

Highlighted Links

Linkage Biosciences announced at the 29th European Immunogenetics and Histocompatibility Conference in Geneva, Switzerland a new distribution partnership with Voden Medical Instruments S.p.a. With a highly experienced leadership team, Voden Medical Instruments has a history of delivering the best quality and most advanced technologies to their customers. This new distribution partnership represents another step forward in providing LinkSēq HLA typing technology to customers around the world. "Voden Medical possesses a long standing record of excellent customer service and proven technical expertise, particularly in the area of HLA testing," said Zachary Antovich, CEO of Linkage Biosciences. "We are looking forward to partnering with Voden to provide LinkSēq HLA typing technology throughout Italy."

About Linkages Biosciences

Linkage Biosciences is a molecular diagnostics company developing and marketing products that dramatically improve and expedite complex genetic testing. LinkSēq is the company's flagship technology that provides the fastest and simplest method of Human Leukocyte Antigen (HLA) testing on the market, covering all classical HLA genes and over 12,000 alleles in a single test. LinkSēq technology utilizes a proprietary assay methodology including reagents and software in combination with standard Real-Time PCR hardware to simplify the determination of complex genetic sequences. The company is headquartered in South San Francisco, California. To learn more please visit www.linkagebio.com

To learn more about Voden Medical Instruments S.p.a., please visit www.vodenmedical.com

Help employers find you! Check out all the jobs and post your resume.

Alliances